• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血友病犬皮肤成纤维细胞中因子IX缺乏的表型纠正

Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.

作者信息

Axelrod J H, Read M S, Brinkhous K M, Verma I M

机构信息

Molecular Biology and Virology Laboratory, Salk Institute, San Diego, CA 92138.

出版信息

Proc Natl Acad Sci U S A. 1990 Jul;87(13):5173-7. doi: 10.1073/pnas.87.13.5173.

DOI:10.1073/pnas.87.13.5173
PMID:2367529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC54284/
Abstract

Primary skin fibroblasts from hemophilic dogs were transduced by recombinant retrovirus (LNCdF9L) containing a canine factor IX cDNA. High levels of biologically active canine factor IX (1.0 micrograms per 10(6) cells per 24 hr) were secreted in the medium. The level of factor IX produced increased substantially if the cells were stimulated by basic fibroblast growth factor during infection. Additionally, we also report that endothelial cells transduced by this virus can produce high levels of biologically active factor IX. We propose that skin fibroblasts and endothelial cells from hemophilia B dogs may serve as potential venues for the development and testing of models for treatment of hemophilia B by retrovirally mediated gene replacement therapy.

摘要

来自血友病犬的原代表皮成纤维细胞被含有犬因子IX cDNA的重组逆转录病毒(LNCdF9L)转导。培养基中分泌出高水平的具有生物活性的犬因子IX(每24小时每10^6个细胞分泌1.0微克)。如果在感染期间用碱性成纤维细胞生长因子刺激细胞,产生的因子IX水平会大幅增加。此外,我们还报告称,被这种病毒转导的内皮细胞能产生高水平的具有生物活性的因子IX。我们提出,来自B型血友病犬的皮肤成纤维细胞和内皮细胞可能成为通过逆转录病毒介导的基因替代疗法治疗B型血友病的模型开发和测试的潜在场所。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fdf/54284/37a0c2f4c7ee/pnas01038-0291-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fdf/54284/4f552eeed0dd/pnas01038-0290-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fdf/54284/37a0c2f4c7ee/pnas01038-0291-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fdf/54284/4f552eeed0dd/pnas01038-0290-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fdf/54284/37a0c2f4c7ee/pnas01038-0291-a.jpg

相似文献

1
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.血友病犬皮肤成纤维细胞中因子IX缺乏的表型纠正
Proc Natl Acad Sci U S A. 1990 Jul;87(13):5173-7. doi: 10.1073/pnas.87.13.5173.
2
Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes.使用腺病毒-聚赖氨酸-DNA复合物在犬血友病B模型中高效转染原代细胞。
Hum Gene Ther. 1994 Mar;5(3):313-22. doi: 10.1089/hum.1994.5.3-313.
3
Canine hemophilia B resulting from a point mutation with unusual consequences.由具有异常后果的点突变导致的犬类血友病B。
Proc Natl Acad Sci U S A. 1989 Dec;86(24):10095-9. doi: 10.1073/pnas.86.24.10095.
4
Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.一只患有B型血友病的拉布拉多猎犬中因子IX基因的完全缺失及因子IX活性的抑制
J Am Vet Med Assoc. 1997 Dec 1;211(11):1418-21.
5
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.体内肝脏基因治疗:血友病B犬中因子IX缺乏症的完全纠正,尽管是短暂的。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2353-7. doi: 10.1073/pnas.91.6.2353.
6
High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.逆转录病毒载体介导人凝血因子IX cDNA在B型血友病患者原代培养人皮肤成纤维细胞中的高效转移与表达
Sci China B. 1992 Feb;35(2):183-93.
7
Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.通过植入来自一名B型血友病患者的基因改造皮肤成纤维细胞,在小鼠中表达人凝血因子IX cDNA 。
Sci China B. 1993 Sep;36(9):1082-92.
8
Gene therapy for hemophilia.血友病的基因治疗。
Curr Opin Mol Ther. 1999 Aug;1(4):493-9.
9
A first step toward gene therapy for hemophilia B?血友病B基因治疗的第一步?
Science. 1993 Oct 1;262(5130):29-30. doi: 10.1126/science.8211125.
10
G244E in the canine factor IX gene leads to severe haemophilia B in Rhodesian Ridgebacks.犬因子 IX 基因中的 G244E 突变导致罗得西亚脊背犬出现严重的血友病 B。
Vet J. 2011 Jan;187(1):113-8. doi: 10.1016/j.tvjl.2010.01.017. Epub 2010 Mar 29.

引用本文的文献

1
Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity.血小板靶向高功能 FIX 基因治疗血友病 B 小鼠,即使存在抗 FIX 免疫。
Blood Adv. 2021 Mar 9;5(5):1224-1238. doi: 10.1182/bloodadvances.2020004071.
2
The function of dog models in developing gene therapy strategies for human health.狗模型在开发基因治疗策略以促进人类健康方面的作用。
Mamm Genome. 2011 Aug;22(7-8):476-85. doi: 10.1007/s00335-011-9348-0. Epub 2011 Jul 6.
3
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

本文引用的文献

1
3,3',5,5' - Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme-immunoassay.3,3',5,5'-四甲基联苯胺作为辣根过氧化物酶在酶免疫测定中的Ames试验阴性显色剂。
J Immunoassay. 1981;2(3-4):187-204. doi: 10.1080/15321818108056977.
2
Medical complications of hemophilia.血友病的医学并发症。
South Med J. 1980 Feb;73(2):155-60. doi: 10.1097/00007611-198002000-00011.
3
The gene structure of human anti-haemophilic factor IX.人抗血友病因子IX的基因结构
在A型血友病、B型血友病、血管性血友病和因子VII缺乏症的犬类模型中的蛋白质替代疗法和基因转移。
ILAR J. 2009;50(2):144-67. doi: 10.1093/ilar.50.2.144.
4
Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins.用于治疗性蛋白质全身递送的肺部无创基因转移。
J Clin Invest. 2002 Aug;110(4):499-504. doi: 10.1172/JCI15780.
5
Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.基因疗法对B型血友病小鼠出血性疾病的持续纠正。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3906-10. doi: 10.1073/pnas.96.7.3906.
6
Prospects for gene therapy in sports medicine.运动医学中基因治疗的前景。
Knee Surg Sports Traumatol Arthrosc. 1996;4(3):180-7. doi: 10.1007/BF01577414.
7
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.对含因子IX基因的腺病毒载体的细胞免疫和体液免疫反应:因子IX和载体抗原的耐受可实现长期表达。
Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1401-5. doi: 10.1073/pnas.92.5.1401.
8
Gene therapy vectors as drug delivery systems.作为药物递送系统的基因治疗载体。
Clin Pharmacokinet. 1995 Mar;28(3):181-9. doi: 10.2165/00003088-199528030-00001.
9
New nucleotide sequence data on the EMBL File Server.欧洲分子生物学实验室文件服务器上的新核苷酸序列数据。
Nucleic Acids Res. 1990 Oct 25;18(20):6181-92. doi: 10.1093/nar/18.20.6181.
10
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.逆转录病毒介导的基因转移在小鼠成纤维细胞植入物中的长期体内表达。
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4626-30. doi: 10.1073/pnas.88.11.4626.
EMBO J. 1984 May;3(5):1053-60. doi: 10.1002/j.1460-2075.1984.tb01926.x.
4
Expression and linkage of genes for X-linked hemophilias A and B in the dog.犬X连锁血友病A和B基因的表达与连锁
Blood. 1973 Apr;41(4):577-85.
5
A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.一种针对因子IX的单克隆抗体,它可抑制因子VIII:钙对因子X激活的增强作用。
J Biol Chem. 1985 Sep 25;260(21):11574-80.
6
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.逆转录病毒包装细胞系的重新设计,以避免重组导致辅助病毒产生。
Mol Cell Biol. 1986 Aug;6(8):2895-902. doi: 10.1128/mcb.6.8.2895-2902.1986.
7
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.莫洛尼鼠白血病病毒包装信号延伸至gag区域的证据。
J Virol. 1987 May;61(5):1639-46. doi: 10.1128/JVI.61.5.1639-1646.1987.
8
Towards gene therapy for hemophilia B.
Mol Biol Med. 1987 Feb;4(1):11-20.
9
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.安全高效地产生具有嗜异源性和嗜亲性宿主范围的重组逆转录病毒。
Proc Natl Acad Sci U S A. 1988 Sep;85(17):6460-4. doi: 10.1073/pnas.85.17.6460.
10
An alternative approach to somatic cell gene therapy.体细胞基因治疗的另一种方法。
Proc Natl Acad Sci U S A. 1988 May;85(9):3150-4. doi: 10.1073/pnas.85.9.3150.